CRHM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.2 -- higher than merely 4.26% of US-listed equities with positive expected earnings growth.
Of note is the ratio of CRH Medical Corp's sales and general administrative expense to its total operating expenses; 87.82% of US stocks have a lower such ratio.
For CRHM, its debt to operating expenses ratio is greater than that reported by 88.9% of US equities we're observing.
Stocks with similar financial metrics, market capitalization, and price volatility to CRH Medical Corp are AQMS, CHCI, FN, OGI, and DHIL.
CRH Medical Corporation Common Shares of Beneficial Interest (CRHM) Company Bio
CRH Medical Corporation, a medical company, provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. The company was founded in 2000 and is based in Vancouver, Canada.
CRHM Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for CRH Medical Corp. To summarize, we found that CRH Medical Corp ranked in the 72th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for CRH Medical Corp ended up being:
CRH Medical Corp's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 72.61% of tickers in our DCF set.
CRHM's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 13%; for context, that number is higher than 72.61% of tickers in our DCF set.
Relative to other stocks in its sector (Healthcare), CRH Medical Corp has a reliance on debt greater than 68.63% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
HUM, UHS, NVO, SKVI, and DVA can be thought of as valuation peers to CRHM, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
(The title for my article will only have meaning for those who have had a colonoscopy - I've had three! But never ignore having such a procedure!) When the stock market, in March, crashed by more than 30% due the full impact of COVID-19 becoming known, I began my due...
Looking For Diogenes on Seeking Alpha | August 18, 2020
CRH Medical Corporation (CRHM) Q2 2020 Earnings Conference Call August 11, 2020 8:30 A.M. ET Company Participants Richard Bear - Chief Financial Officer Tushar Ramani - Chief Executive Office Jay Kreger - President of CRH Anesthesia Tom Sanders - Vice President of Commercial Development Conference Call Participants Richard Close -...
CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM), announces that it has completed an accretive transaction whereby the Company has acquired a 51% interest in Central Virginia Anesthesia Associates, LLC ("Central Virginia"), a gastroenterology ("GI") anesthesia practice located in Virginia.